You Searched For "atai life sciences" and got 20 results
Sort By:
Peter Thiel-backed psychedelics company plans to raise $100 million in an IPO
Atai Life Sciences, a company that aims to use psychedelic compounds for therapeutic uses, is plann…
Emily Graffeo  Â
A magic mushroom firm backed by Peter Thiel is now worth $2 billion and reportedly eyeing an IPO
Atai Life Sciences recently raised $157 million in its Series D funding round, and reports say its …
Annabelle Williams  Â
The stock of psychedelics giant Atai is tumbling after a treatment failed to help patients in a trial
Atai Life Sciences' ketamine-based therapy failed to help patients with depression in a mid-stage t…
Sarah Braner  Â
ATAI has raised $100 million to turn psychedelics into treatments for depression and anxiety. Now the unusual biotech is gearing up to raise millions more for the next phase of human testing.
Heading a psychedelics company wasn't in his plans, but he attributes where he is today - from fres…
Yeji Jesse Lee  Â
CULTIVATED: Inside the cannabis industry's meltdown, teen use creeps up in legal states, and an exclusive look at industry salaries
I put on my science reporter hat for the first time in over a year and took a look at a new study t…
Jeremy Berke  Â
A top psychedelic scientist says 'the climate's looking good' for magic mushrooms and MDMA to turn into medicines at a gathering of the world's billionaires
Last summer, a startup backed by Silicon Valley tech mogul Peter Thiel churned out enough of the ac…
Erin Brodwin,Alyson Shontell  Â
Evidence is mounting that psychedelic drugs can help treat diseases. Here are the most promising uses
Two for-profit companies are currently leading the research in the space. The first, called Compass…
Erin Brodwin  Â
A Peter Thiel-backed startup has raised $25 million to unleash a 'virgin market of for-profit psychedelic research'
Compass Pathway's study, which got FDA approval in August, looks at the effect of three different d…
Erin Brodwin  Â
Cannabis power players of New Jersey and Arizona
Welcome to Insider Cannabis, where we're bringing you an inside look at the deals, trends, and pers…
Jeremy Berke,Yeji Jesse Lee  Â
Billionaire FBI informant Peter Thiel dished about two Kremlin invites to private Putin meetings
Vladimir Putin's outreach to Peter Thiel, made through a Russian diplomat, occurred in 2018 at a pa…
Mattathias Schwartz,Hans-Mart…  Â
New York cannabis gold rush
Welcome to Insider Cannabis, where we're bringing you an inside look at the deals, trends, and pers…
Jeremy Berke,Yeji Jesse Lee  Â
Top cannabis stock picks for 2021
Welcome to Insider Cannabis, where we're bringing you an inside look at the deals, trends, and pers…
Jeremy Berke,Yeji Jesse Lee  Â
Investors are eyeing psychedelics as the next big trend in healthcare as medical-grade treatments inch toward FDA approval
JR Rahn, founder of MindMed - a company that develops psychedelic-based medication - said that the …
Yeji Jesse Lee  Â
Dispensed: Coronavirus spreads, drugmakers scramble to respond, and the latest magic mushroom startups
Featured Digital Health Articles: - Telehealth Industry: Benefits, Services & Examples - Valu…
Andrew Dunn  Â
10 things before the opening bell
The Fed must balance between the markets and the economy, and Deutsche Bank's recession forecast fo…
Phil Rosen  Â
10 things in tech you need to know today
SpaceX is launching astronauts into space today, and Amazon's senior execs are leaving in droves: H…
Jordan Parker Erb  Â
What GTI and Trulieve told Wall Street
Welcome to Insider Cannabis, where we're bringing you an inside look at the deals, trends, and pers…
Jeremy Berke,Yeji Jesse Lee  Â
Famed investor Michael Novogratz said psychedelics will be the next 'short-term bubble' after cannabis - and predicts Compass Pathways will go public this year
Featured Digital Health Articles: - Telehealth Industry: Benefits, Services & Examples - Valu…
Jeremy Berke,Bradley Saacks  Â
The 26 cannabis startups set to soar in 2021
Welcome to Insider Cannabis, where we're bringing you an inside look at the deals, trends, and pers…
Jeremy Berke,Yeji Jesse Lee  Â
CULTIVATED: Border towns boom, Wall Street warns against Canadian stocks, MedMen earnings, and more
Perhaps emblematic of the growing interest in the world of psychedelics from the cannabis community…